RHA X-Series

With TEOSYAL^®RHA, hyaluronic acid is going through an innovative manufacturing process³, in order to create the first resilient hyaluronic acid⁴ dedicated to facial dynamism.

1. TEOXANE Laboratories crosslinking method is a patented process. 2. TEOSYAL^®RHA keeps its mechanical properties on a large range of strain or stress constraints (dynamic G’) Report Rheological characterizations of hyaluronic acid gels. Rheonova (University of Grenoble, France). Data on file - Patent pending. TEOSYAL^®RHA 1 to 4 are medical devices class III (CE 0086), please refer to instructions of use. 3. TEOXANE Laboratories crosslinking method is a patented process. 4. TEOSYAL^®RHA keeps its mechanical properties on a large range of strain or stress constraints (dynamic G’) Report Rheological characterizations of hyaluronic acid gels. Rheonova (University of Grenoble, France). Data on file - Patent pending.